Evrópusambandið - danska - EMA (European Medicines Agency)

mylan pharmaceuticals limited - gefitinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - gefitinib mylan er angivet som monoterapi til behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke‑småcellet lungekræft (nsclc) med aktiverende mutationer af egfr‑tk.

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

navamedic asa - clindamycinphosphat - infusionsvæske, opløsning - 300 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

abacus medicine a/s - diclofenacnatrium - depottabletter - 75 mg

Evrópusambandið - danska - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hypofysen og hypothalamus hormoner og analoger - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - protaminsulfat - injektions-/infusionsvæske, opløsning - 10 mg/ml

Evrópusambandið - danska - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatitis b overflade antigen - hepatitis b - vacciner - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - diclofenacnatrium - depottabletter - 100 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - diclofenacnatrium - depottabletter - 75 mg

Evrópusambandið - danska - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - diclofenacnatrium - depottabletter - 100 mg